About SSMJ

The South Sudan Medical Journal exists to inform, educate and positively influence the development of health services in South Sudan and beyond. The Journal is published quarterly by the Health and Social Sciences Research Institute - South Sudan (HSSRI-SS) in February, May, August and November.

Vision

To see well-trained, skilled professionals delivering high quality healthcare to the population of the South Sudan and beyond

Mission

To publish research and clinical guidance that will positively influence the development of healthcare services in South Sudan and beyond.

Scope

SSMJ publishes all types of articles: original research, reviews, survey reports/KAP studies, discussions and commentaries as well as case studies, clinical guidance and letters to the editor, in all fields of medicine and public health.

History of SSMJ

The South Sudan Medical Journal (SSMJ) was started in February 2008, as the Southern Sudan Medical Bulletin (SSMB), a joint venture between South Sudanese and British doctors who wanted to make a free, accessible journal for all branches of healthcare in South Sudan. It published regular quarterly issues that were distributed and read by healthcare staff in government and non-government organisations (NGOs) throughout the region.

On the 16^th April 2009 the SSMB became a charity and was renamed the Southern Sudan Medical Journal and in July 2011, in line with national independence, was renamed as the South Sudan Medical Journal.

The team recognized the importance of understanding the cultural values of the people we serve. In line with this, half of our staff are local healthcare professionals working in the South Sudan, whilst the rest of the team are based in the UK. This enables us to contribute effectively to healthcare development in the country.

----

Note: Every effort has been made to ensure that the information and the drug names and doses quoted in this journal are correct. However readers are advised to check the doses before making prescriptions. Unless otherwise stated the doses quoted are for adults.